Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
T.CelestinoI.CoppoL.HolmgrenA.et al
The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al
Glucagon receptor agonism stimulates intestinal smooth muscle directly and triggers pro-emetic signaling in the brainstem
Sequence analysis of A3, B3, and A4 crystallins completes the identification of the major proteins in young human lens
GHRP-6 Clinical Evidence Context The biology is well documented
US$ 23.68
US$ 28.48
US$ 20.70
US$ 23.35
US$ 24.35
US$ 29.96
US$ 20.75
US$ 28.86
US$ 21.10
US$ 21.83
